Search - tctmd.com

Displaying 1 - 20 of 42

Sort: Relevancy | Date

FDA Expands Evolut Indication to Include Redo TAVI

News Daily News

FDA Expands Evolut Indications to Include Redo TAVI

Yael L. Maxwell

August 29, 2025

News Conference News SCAI 2025

More Patient-Prosthesis Mismatch With TAVI in Women, but 5-Year Survival Unaffected

L.A. McKeown

May 02, 2025

News Features

What’s in a Name: Is It Time to Choose Between TAVI and TAVR?

Yael L. Maxwell

March 27, 2025

News Conference News CRT 2025

SMART: Small Aortic Annuli Still Fare Best With Self-Expandable Valves at 2 Years

L.A. McKeown

March 10, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2025

Shelley Wood

February 28, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2024

Shelley Wood

December 03, 2024

News Daily News

Little Pre- and Postmarket Testing for Most Recalled CV Devices

Michael O'Riordan

September 16, 2024

News Daily News

Knowns and Unknowns in Subclinical Aortic Valve Thrombosis

Caitlin E. Cox

June 21, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2024

Shelley Wood

May 31, 2024

News Conference News STS 2024

TAVI, SAVR Almost Equally Performed in California Patients Under 60

Yael L. Maxwell

February 01, 2024

News Daily News

Obstructive CAD Can Be Left Alone Before TAVI, Observational Data Suggest

Michael O'Riordan

January 30, 2024

News Features

Going Solo: Can TAVI Be Performed Without a Surgical Safety Net?

Michael O'Riordan

January 22, 2024

News Conference News TCT 2023

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

Michael O'Riordan

October 24, 2023

News Conference News EACTS 2023

AUTHEARTVISIT Reignites RCT vs Real-world Data Debate for AV Repair

Michael O'Riordan

October 09, 2023

News Conference News AATS 2023

Beware High-Risk TAVI in Patients With Low-Lying Coronaries

Michael O'Riordan

May 11, 2023

News Daily News

FDA Alert: Possible Early Deterioration of Abbott Trifecta SAVR Valves

Todd Neale

February 27, 2023

News Daily News

Top Structural Heart News of 2022

L.A. McKeown

January 06, 2023

News Daily News

Left-Sided Bioprosthetic Valves Often Dysfunctional in Pregnant Women

L.A. McKeown

November 21, 2022

News Daily News

Subclinical Thrombosis After TAVI Benign, at Least to 3 Years

Michael O'Riordan

June 07, 2022

Advertisement

FDA Expands Evolut Indications to Include Redo TAVI

More Patient-Prosthesis Mismatch With TAVI in Women, but 5-Year Survival Unaffected

What’s in a Name: Is It Time to Choose Between TAVI and TAVR?

SMART: Small Aortic Annuli Still Fare Best With Self-Expandable Valves at 2 Years

TCTMD’s Top 10 Most Popular Stories for February 2025

TCTMD’s Top 10 Most Popular Stories for November 2024

Little Pre- and Postmarket Testing for Most Recalled CV Devices

Knowns and Unknowns in Subclinical Aortic Valve Thrombosis

TCTMD’s Top 10 Most Popular Stories for May 2024

TAVI, SAVR Almost Equally Performed in California Patients Under 60

Obstructive CAD Can Be Left Alone Before TAVI, Observational Data Suggest

Going Solo: Can TAVI Be Performed Without a Surgical Safety Net?

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

AUTHEARTVISIT Reignites RCT vs Real-world Data Debate for AV Repair

Beware High-Risk TAVI in Patients With Low-Lying Coronaries

FDA Alert: Possible Early Deterioration of Abbott Trifecta SAVR Valves

Top Structural Heart News of 2022

Left-Sided Bioprosthetic Valves Often Dysfunctional in Pregnant Women

Subclinical Thrombosis After TAVI Benign, at Least to 3 Years

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content